May 2013 Skin & Eye Health
Early treatment is crucial for the prevention of irreversible damage.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
2
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
3
Fentanyl-Responsive Microneedle Patch Automatically Releases Naloxone in Preclinical Study
4
Delegating to Technicians: The Key to Pharmacists Practicing at Top of License
5